SHIMANO STEPS: Quarter of Europeans Now Willing to Commute to Work by E-bike
SHIMANO STEPS today reveals the results of the largest European e-bike study looking at people’s willingness to commute to work by e-bike. The independent research* of over 12,000 people across 10 markets, reveals that 24% of European commuters would consider switching to an e-bike. Almost half of the population of the Netherlands (47%) would commute to work by e-bike, the highest in Europe, while 39% of people in Spain and 33% in Italy would make the switch.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190403005809/en/
Willingness to commute to work by e-bike across Europe (Photo: Business Wire)
Ranking of countries who would consider making the switch to an e-bike for their commute:
The SHIMANO STEPS research reveals that across Europe, the main reasons to consider commuting to work by e-bike are “to keep fit” (34%) “to protect the environment” (30%) and “to save money” (30%). People are put off riding an e-bike to work because of “the possibility of bad weather” (37%), “the cost of an e-bike” (34%) and “arriving to work sweaty” (25%).
People in the UK are the least likely to choose an e-bike to commute to work, with only 11% willing to consider making the switch, well below the European average. The “possibility of bad weather” (43%) and “arriving to work sweaty” (35%) proved to be the main reasons for the UK public to resist the switch to an e-bike.
“We’re seeing huge growth in the e-bike market across Europe and this research highlights the likelihood of widespread adoption of e-bikes to commute to work in the future,” said Jeroen Van Vulpen, Brand Manager SHIMANO STEPS. “We know that there is already a strong cycling culture in specific countries, where those who've made the switch to an e-bike have found that bad weather is rarely an insurmountable problem and sweat is a thing of the past when you let the electric assistance take the strain. It’s really encouraging to see that across all markets, people are willing to switch to an e-bike to keep fit and protect the environment.”
“We welcome this research from Shimano, which confirms that there is huge potential for power assisted bicycles, especially combined with the building of longer distance cycle highways,” said Ádám Bodor, Advocacy Director, European Cyclists' Federation. “These bikes are a great addition to the bicycle family contributing to sustainable active transport by being available to substitute ever longer car journeys.”
NOTES TO EDITORS
1. All figures, unless otherwise stated, are from YouGov Plc. Sample size: 14606 adults. Fieldwork done between 30th January - 13th February 2019. Survey was carried out online. The figures are weighed and represent all adults (aged 18+) in each country.
2. “commuters” refers to people who work.
SHIMANO STEPS European-wide research results:
Top reasons to make the switch:
1. To keep me fit (34%)
2. To protect the environment (30%)
3. To save money (30%)
Top barriers for making the switch:
1. The possibility of bad weather (37%)
2. E-bikes are too expensive (34%)
3. Commute being too far to travel by e-bike (31%)
For more information:
Ben Hillsdon, SHIMANO Europe BV
+31 (0)6 12 20 33 90
About Business Wire
(c) 2018 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
NetMedia Group takes over the management of financial platform Investing.com's European advertising space23.7.2019 08:07:00 CEST | Press release
NetMedia Group, media B2B leader in Europe in the world of business information, and Investing.com, second largest financial services and information platform in Europe, are to form a partnership, with NetMedia Group handling the sales of advertising space for Investing.com. With average traffic of over 21 million unique users totaling over 175 million sessions in 31 countries, Investing.com is one of the top three global financial websites and has the most downloaded financial management app. For Investing.com, the aim of the new partnership is to maximize digital advertising revenue through the NetMedia Group's European teams. NetMedia Group's goal is to expand its advertising services by offering a new vertical market for finance, in order to boost the range of services it has available to decision-makers for upper socio-professional target groups. About NetMedia Group: NetMedia Group is a B2B media group located in five countries across Europe; it employs nearly 150 staff members a
Frost & Sullivan Names Luminati the 2019 Global Market Leader in the Enterprise IP Proxy Networks Market23.7.2019 08:00:00 CEST | Press release
Luminati, the Israeli company that allows businesses to experience the web through the eyes of individual consumers throughout the world, today announced it has received a Market Leadership Award in the first independent analysis of the sector. Luminati’s enterprise IP proxy network (IPPN) services for global retailers, brand owners and advertising networks feature strongly in the report by analyst firm Frost & Sullivan. The report outlines a relatively new, but rapidly growing market and recognizes Luminati’s leading position in the provision of solutions that are increasingly important for businesses to remain competitive and compliant in the digital landscape. [S1] “The market for enterprise IP proxy network solutions is in its early growth stages, basically being invented by Luminati only a few years ago. With the more specialized targeting of customers by demographics and location, companies are finding it more difficult than ever to do competitive analysis and verify advertising,
LifeSpan BioSciences Releases Best-In-Class PathPlus™ Top Performing Immunohistochemistry Antibodies for Cancer Targets23.7.2019 08:00:00 CEST | Press release
LifeSpan BioSciences, Inc. (LSBio™), the industry leader in molecular pathology, today announced the first release of its PathPlus™ series of antibodies. These 565 antibodies were selected from among thousands tested and identified to be the best performing reagents for immunohistochemical detection of 200 high-value cancer targets in formalin-fixed paraffin-embedded human tissues. Antibody validation has become an industry roadblock as thousands of antibodies have become available to customers who face difficult choices in determining which antibodies are the best performers for each application, including immunohistochemistry, flow cytometry, ELISA, Western blot, or immunofluorescence. Antibodies that perform well in one assay, such as IHC, may not be the most specific reagent for another assay, such as flow cytometry. “Identifying the optimal reagents to use in their experiments is a pain point for researchers,” said LSBio CEO Heather Holemon. “There is a tremendous need to identify
IDEMIA Will Present Its H1 2019 Financial Results to Investors on July 30, 201923.7.2019 07:00:00 CEST | Press release
IDEMIA, the world leader in Augmented Identity, today announced that it will present its H1 2019 financial results to investors on Tuesday July 30, 2019. Yann Delabrière (CEO) and Laurent Lemaire (CFO) will be presenting the financial results and taking questions the same day at 3:30 pm CET (2:30 pm London Time / 9:30 am New York Time). For more information, please refer to our website: https://investors.idemia.com/ About IDEMIA IDEMIA, the global leader in Augmented Identity, provides a trusted environment enabling citizens and consumers alike to perform their daily critical activities (such as pay, connect and travel), in the physical as well as digital space. Securing our identity has become mission critical in the world we live in today. By standing for Augmented Identity, an identity that ensures privacy and trust and guarantees secure, authenticated and verifiable transactions, we reinvent the way we think, produce, use and protect one of our greatest assets – our identity – whet
Gain Therapeutics SA Announces Award Notification of a €1.4M Grant Support From Eurostars-2 Together With the Institute for Research in Biomedicine and Neuro-Sys SAS After Having Scored 2nd Among 325 Eligible Applications23.7.2019 06:30:00 CEST | Press release
Gain Therapeutics SA, a biotechnology company discovering and developing novel therapeutics to target lysosomal enzymes involved in inborn errors of metabolism and in central nervous system (CNS) diseases, today announced that together with Dr. Maurizio Molinari from the Institute for Research in Biomedicine, Bellinzona (Switzerland) affiliated to the Università della Svizzera italiana (USI) and Neuro-Sys SAS in Gardanne (France), it has received funding support from Eurostars-2 joint programme with co-funding from the European Union Horizon 2020 research and Innosuisse – Swiss Innovation Agency. This grant will further strengthen Gain Therapeutics’s novel therapeutic approach for targeting rare diseases in the CNS, where lysosomal misfolded enzymes lead to sever clinical phenotypes, where no treatment is available and/or high unmet medical needs still do afflict patients, families and carers. This funding will support the development of the drugs portfolio of Gain Therapeutics for the
iBASIS Accelerates Growth With JC Geha as Chief Operating Officer23.7.2019 06:00:00 CEST | Press release
iBASIS, provider of communications solutions for operators and digital players worldwide, today announced the appointment of JC Geha as its COO. He will take his new post effective August 1, and be based at iBASIS’ headquarters in Lexington, Massachusetts. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190722005757/en/ JC Geha (Photo: Business Wire) Formerly Senior Vice President, Head of International Technology and Services for Deutsche Telekom, and of Managed Services for Ericsson, Geha brings to iBASIS an impressive track record of profitable growth, technology and digital transformation expertise. His expertise spans 25 years of deep global industry relationships across the United States, Europe, Middle East, and Africa. Geha will lead iBASIS’ global operations, engineering, IT, and product development. He will report to iBASIS’ CEO and founder of the Group Tofane Global, Alexandre Pébereau, with the responsibility of g